An 8 Week Study Looking At The Efficacy, Toleration And Safety Of SS-RBX For Stress Urinary Incontinence.

Completed · Phase 2

Conditions studied: Urinary Incontinence, Stress

In brief

A study designed to assess the efficacy, toleration and safety of SS-RBX for the treatment of stress urinary incontinence.

Key facts

Study ID

NCT00138749

Run by

Pfizer

People needed

402

Starts

2004-11-01

Expected to finish

2006-08-01

Last updated by the study team

2011-04-07

Who can join

Age: 18 and older, up to 65. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Clinically significant stress urinary incontinence

You may not qualify if…

• History or evidence of any relevant confounding urological or neurological disease

Where it is running

• Pfizer Investigational Site — Sun City, Arizona, United States
• Pfizer Investigational Site — Tucson, Arizona, United States
• Pfizer Investigational Site — Tucson, Arizona, United States
• Pfizer Investigational Site — Little Rock, Arkansas, United States
• Pfizer Investigational Site — Atherton, California, United States
• Pfizer Investigational Site — Carmichael, California, United States
• Pfizer Investigational Site — Laguna Woods, California, United States
• Pfizer Investigational Site — Murrieta, California, United States
• Pfizer Investigational Site — Newport Beach, California, United States
• Pfizer Investigational Site — Sacramento, California, United States
• Pfizer Investigational Site — San Diego, California, United States
• Pfizer Investigational Site — Tarzana, California, United States
• Pfizer Investigational Site — Temecula, California, United States
• Pfizer Investigational Site — Torrance, California, United States
• Pfizer Investigational Site — Vista, California, United States
• Pfizer Investigational Site — Aurora, Colorado, United States
• Pfizer Investigational Site — Denver, Colorado, United States
• Pfizer Investigational Site — Denver, Colorado, United States
• Pfizer Investigational Site — Wheat Ridge, Colorado, United States
• Pfizer Investigational Site — New London, Connecticut, United States
• Pfizer Investigational Site — Waterbury, Connecticut, United States
• Pfizer Investigational Site — Aventura, Florida, United States
• Pfizer Investigational Site — New Port Richey, Florida, United States
• Pfizer Investigational Site — Panama City, Florida, United States
• Pfizer Investigational Site — Anchorage, Alaska, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.